The 1,1'-(5,5'-(1,3-phenylene)bis(3-aryl-4,5-dihydro-1H-pyrazole-5,1-diyl))di-ethanone (5a-e) and 1,3-bis(1-phenyl-3-(aryl)-4,5-dihydro-1H-pyrazol-5-yl)benzene (6a-e) were synthesized by addition of hydrazine hydrate and/or phenylhydrazine to 1,3-phenylene-bis-chalcone derivatives (3a-e), respectively. The structures of obtained compounds (5a-e and 6a-e) were characterized using the spectroscopic methods (NMR, IR) and elemental analysis. Addition, the in vitro antibacterial activities of compounds (5a-e) was tested against the five human pathogenic bacteria. Gentamycin and Fluconazole were used as positive control. The results were given as inhibition zone (mm) and the compounds 5d and 5e showed the same activity with standard (Fluconazole) against C. albinas.
Introduction
Pyrazole ring is well known for their wide range of biological activities such as analgesic, antiinflammatory, antipyretic, antiarrhythmic, sedative, muscle relaxant, psychoanaleptic, monoamine oxidase inhibitor, anti-diabetic and antimicrobial properties. [1] [2] [3] [4] [5] [6] [7] [8] Addition, pyrazole derivatives play an important role in the development of pesticides and medicines. Several of pyrazole products are available and widely used as fungicides, antiviral agents, analgesic agents, insecticides and herbicides. [9] [10] [11] For thus, pyrazole derivatives have attracted considerable attention in the recent years for their diverse biological activities. [12] [13] [14] [15] [16] [17] In this paper, the novel 1,1'-(5,5'-(1,3-phenylene)bis(3-aryl-4,5-dihydro-1H-pyrazole-5,1-diyl))diethanone (5a-e) and 1,3-bis(1-phenyl-3-(aryl)-4,5-dihydro-1H-pyrazol-5-yl)benzene (6a-e) were synthesized in good yields and evaluated the antibacterial activities of compounds (5a-e) against some human pathogenic bacteria.
Experimental
IR spectrums (KBr) were recorded on a Jasco FT/IR-430 spectrometer. 1 H and 13 C NMR spectra were recorded on a Bruker Avance DPX-400 instrument. As internal  (0.00) for standards served TMS 1 H NMR and CDCl 3 (77.0) for 13 C NMR spectra, J values are given in Hz. Melting points were measured on Electrothermal 9100 apparatus. Elemental analyses were obtained from a LECO CHNS 932 Elemental Analyzer. The major chemicals were purchased from Sigma-Aldrich and Fluka.
General Procedure for the Synthesis of Bis-Chalcone Derivatives (3a-e):
18-22 Aril ketones derivatives (1a-h) (1 mmol) in EtOH (20 ml) were added to NaOH (2.5 M, 6 ml). The mixture was stirred for 3 min and was added (2) (1 mmol) and was stirred for 4 h at r.t. Start mixing a few minutes after it was observed that the collapse occurred. By reaction the precipitate formed was filtered off. After washing with ethanol several times with methylene chloride / hexane (3/7) mixture was crystallized.
(2E,2'E) -3,3'-(1,3-phenylene) [23] [24] [25] [26] [27] Bis-chalcone (1a-h) (1 mmol) and hydrazine hydrate (4 mmol) in acetic acid and/or phenylhydrazine (4 mmol) in acetic acid/ethanol mixture were refluxed for 4 and 8 hours, respectively. The reaction mixture was poured into ice-bath, at the end of the reaction and was checked with pH paper to ensure neutralization of the medium by addition of ammonia. It was observed that the collapse occurs in the mixture to stand overnight and the precipitate formed was filtered off, was allowed to dry. The resulting material was obtained as a pure. 
General Method for the Synthesis of 1,4-Phenylene-bis-N-acetylpyrazole (5a-h) and 1,4-Phenylene-bis-N-phenylpyrazole Derivatives (7a-h):

5,5'-(1,3-phenylene)bis(1-acetyl-3-phenyl-4,5-dihydro-1H-pyrazole) (5a)
:
5,5'-(1,3-phenylene)bis[1-acetyl-3-(4-methylphenyl)-4,5-dihydro-1H-pyrazole] (5b):
5,5'-(1,3-phenylene)bis[1-acetyl-3-(4-methoxyphenyl)-4,5-dihydro-1H-pyrazole] (5c):
1,3-bis(1,3-diphenyl-4,5-dihydro-1H-pyrazol-5-yl)benzene (7a):
1,3-bis(1-phenyl-3-(p-tolyl)-4,5-dihydro-1H-pyrazol-5-yl)benzene (7b)
1,3-bis(3-(4-methoxyphenyl)-1-phenyl-4,5-dihydro-1H-pyrazol-5-yl)benzene (7c):
1,3-bis(3-(4-bromophenyl)-1-phenyl-4,5-dihydro-1H-pyrazol-5-yl)benzene (7d):
1,3-bis(3-(4-chlorophenyl)-1-phenyl-4,5-dihydro-1H-pyrazol-5-yl)benzene (7e)
Antimicrobial activity
The C. albicans was grown by 24 h of incubation at 25
• C in Sabouraud Dextrose Broth (Merck) and the other bacteria were grown by 24 h of incubation at 36
• C in Mueller-Hinton Broth (Merck). Antibacterial activities were determined by disc-diffusion method 28, 29 using 100 µL of suspension containing 10 8 CFU/mL of bacteria and 10 6 CFU/mL of yeast spread on Nutrient Agar (NA) and Sabouraud Dextrose Agar (SDA) medium, respectively. Starting dilution (1/10 mg/ml) was prepared by dissolving each of the compounds in DMSO. The blank discs (Oxoid = 6 mm in diameter) were impregnated with 20 µL of each substance and placed on the inoculated agar. Gentamycin and Fluconazole were used as standard to determine the sensitivity of a strain of each microbial species tested. The inoculated plates were incubated at 37
• C for 18 hours.
Results and Discussion
Chemistry
The starting materials 3a-e, 1,3-phenylene-bis-chalcone, were synthesized of well known Claisen-Schmidt condensation from the reaction of isophthaldehyde (1) with related ketones (2a-e) in the presence of NaOH in EtOH at r.t. for 4 hours (Scheme1, Table 1 ). According to our literature surveys, compound 3a is known the others are unknown. 18 The structures of compounds were explained on the basis of spectral data (NMR, IR) and elemental analysis.
Then, the novel 1,3-phenylene-bis-N-acetyl-(5a-e), 1,1'-(5,5'-(1,3-phenylene)bis(3-aryl-4,5-dihydro-1H-pyrazole-5,1-diyl))diethanone, and bis-N-phenylpyrazole (7a-e), 1,3-bis(1-phenyl-3-(aryl)-4,5-dihydro-1H-pyrazol-5-yl)benzene, derivatives were obtained by addition of hydrazine hydrate and/or phenyl hydrazine to bis-chalcone derivatives (3a-e) in acetic acid and/or acetic acid/ethanol at reflux conditions for 4 and 8 hours, respectively. The structures of obtained bis-N-acetylpyrazole (5a-e) and bis-N-phenylpyrazole (7a-e) derivatives were characterized using the spectroscopic methods (NMR, IR) and elemental analysis, and comparison with literature data. 27 All spectral data are in good agreement with the proposed structures. 3(a-e), 5(a-e) and 7(a-e) 
Scheme 1. Synthetic pathway of compounds
Biological assays
Antimicrobial activity results
The synthesized compounds (5a-e) were tested for their antibacterial activity against five different types of human pathogenic bacterial strains, Enterococcus faecalis (ATCC® 29212), Staphylococcus aureus (ATCC®29213) which are Gram-positive bacteria, Escherichia coli (ATCC®25922), Pseudomonas aeruginosa (ATCC®27853), which are Gram-negative bacteria and Candida albicans (ATCC®1213) which is yeast. Gentamycin and Fluconazole were used as standard and DMSO was used as negative control in the tests. The results were given as inhibition zone (mm) compared with standards ( Table 2) . Table 1 . Synthesized compounds 3(a-e), 5(a-e) and 7(a-e According to Table 2 , compounds 5b showed low activity with 3 mm of inhibition zone and 5c showed good activity wıth 6.5 mm of inhibition zone against E. faecalis compared to standard (Gentamycin = 10.5 mm), and the others compounds were inactive. Also, compounds 5b and 5c displayed good activity with 5.5 mm and 6 mm of inhibition zone against S. aereus compared to standard (Gentamycin = 8.25 mm), and the others were inactive. Addition, compounds 5b, 5c and 5e demonstrated low activity with 1.5 mm, 2.5 mm and3.75 mm of inhibition zone, respectively, against E. coli 111 compared to standard (Gentamycin = 11.5 mm), and the others were inactive. All compounds 5a-e exhibited low activity with 0.75-4.5 mm of inhibition zone against P. aeroginosa compared to standard (Gentamycin = 9.75 mm). The most active compounds were 5d (10.5 mm) and 5e (8.0 mm), and they were showed almost the same activity with standard Fluconazole (10.75 mm) against C. albicans. According to these results, further researches can be performed for compounds 5d and 5e as potential antibacterial agents against C. albicans. 
Antioxidant Activity Test
The synthesized compounds were also tested in terms of Trolox equivalent and the test results show that all of the compounds have antioxidant capacity (Table 3) . Table 3 . Antioxidant activities of compounds 5(a-e) 5a 5b 5c 5d 5e Antioxidant activity (mmol Trolox eq./L.): 2.3 3.1 2.6 0.8 3.9
Conclusion
Conclusion, The 1,3-Phenylene-bis-N-acetylpyrazoles (5a-e) and 1,3-Phenylene-bis-Nphenylpyrazoles (6a-e) were synthesized by addition of hydrazine hydrate and/or phenylhydrazine to 1,3-phenylene-bis-chalcone derivatives (3a-e), respectively in high yields. Addition, the in vitro antibacterial activities of compounds (5a-e) was tested against the five human pathogenic bacteria. Among the compounds 5a-e, compounds 5d and 5e showed the same activity with standard (Fluconazole) against C. albinas.
